Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04614194
Title Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole

Abemaciclib + Letrozole

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.